spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  xerostomia 

 HSMN NewsFeed - 24 Sep 2018
Cumberland Pharmaceuticals Announces Senior Music Industry Executive Joins Its Board Of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Aug 2018
Cumberland Pharmaceuticals Appoints New Senior Executive
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2018
Cumberland Pharmaceuticals Expands into Oncology Support
Biopharmaceuticals Oncology Licensing Distribution
 HSMN NewsFeed - 25 Sep 2017
Cumberland Pharmaceuticals Launches Promotion of Totect(R) in The U.S. for Emergency Oncology Intervention
Biopharmaceuticals Oncology Product Launch
 HSMN NewsFeed - 8 May 2017
Lamellar Biomedical Raises £5.75 Million in Series C Fund Raising led by Invesco
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Aug 2016
Acacia Pharma Announces Positive Results From a Pivotal Phase 3 Trial of BAREMSIS(TM) for the Treatment of Post-Operative Nausea & Vomiting
Biopharmaceuticals
 HSMN NewsFeed - 17 Feb 2014
BMG PHARMA S.r.l - Milan, Italy - Has Granted Exclusive Distribution Rights to Samyang Biopharmaceutical Corporation for GelX(R) in the Territory of South Korea
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 14 Mar 2012
DFINE Announces First U.S. Patient Treated with the STAR Ablation System
Devices Orthopaedic Neurosurgery Oncology
 HSMN NewsFeed - 10 Dec 2010
BioVex Commences OncoVEXGM-CSF Phase 3 Trial in Head and Neck Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jul 2010
Cyclacel Pharmaceuticals Announces FDA Orphan Drug Designation for Sapacitabine in Both AML and MDS
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Nov 2009
Advances in Radiation Therapy Enable Doctors to Improve the Quality of Treatments for Patients With Head and Neck Cancer
Devices Oncology
 HSMN NewsFeed - 20 Apr 2009
SpePharm Announces the European Launches of Two New Products: MuGard and Xerotin
Biopharmaceuticals Oncology Distribution
 HSMN NewsFeed - 15 Apr 2009
TorreyPines Therapeutics, Inc. Hires Advisor to Evaluate Strategic Alternatives
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2009
EUSA Pharma Completes the European Launch of CAPHOSOL(R) for Prevention and Treatment of Oral Mucositis Caused by Cancer Therapy
Biopharmaceuticals
 HSMN NewsFeed - 2 Dec 2008
TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia
Biopharmaceuticals
 HSMN NewsFeed - 12 Nov 2008
TorreyPines Therapeutics Appoints Evelyn Graham Chief Executive Officer and a Member of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Oct 2008
GlaxoSmithKline to Acquire the Leading Dry Mouth Brand, Biotene
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 7 Jul 2008
Xclair(R) Reported to Be Safe and Effective in Study Published in European Journal of Dermatology
Biopharmaceuticals Dermatology Oncology
 HSMN NewsFeed - 27 May 2008
Cyclacel's Sapacitabine Receives Orphan Designation for AML & MDS From EU Regulators
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 11 Mar 2008
EUSA Pharma to Acquire US Specialty Oncology Company Cytogen
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Mar 2008
Auriga Laboratories Announces FDA Approval of Liquadd(TM) (Dextroamphetamine Sulfate) Oral Solution for the Treatment of ADHD and Upcoming Product Launch
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Feb 2008
Marillion Pharmaceuticals and Cytokine PharmaSciences Announce License Agreement for Xerostomia Treatment
Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 Jan 2008
Frank R. Greico Named CEO of Auriga Laboratories
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Oct 2007
Cyclacel Pharmaceuticals Acquires Specialty Pharmaceutical Business Focused on the Oncology Market
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 11 Sep 2007
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Sep 2007
ImClone Settles Patent Lawsuit and Gains Rights to Additional Intellectual Property
Biopharmaceuticals Oncology Litigation Licensing
 HSMN NewsFeed - 28 Aug 2007
Auriga Laboratories Appoints Frank R. Greico as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jul 2007
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Jul 2007
A.T.S. Pharmaceuticals, A division of Auriga Laboratories Launches Xyralid(TM) LP Lotion
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 20 Jul 2007
Auriga Laboratories Appoints Lisa Tripodi as Vice President of Trade Relations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jul 2007
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Jul 2007
Auriga Laboratories Appoints Rick Coulon Vice President of Consumer Brands
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jun 2007
Auriga Laboratories Appoints Leonhard Dreimann and Thomas Heck to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jun 2007
Auriga Laboratories Announces the Formation of A.T.S. Pharmaceuticals, a Specialty Division dedicated to Dermatology and Gastroenterology
Biopharmaceuticals Dermatology Gastroenterology
 HSMN NewsFeed - 11 Jun 2007
FDA Accepts and Grants Priority Review of ERBITUX(R) (Cetuximab) sBLA for Overall Survival in Patients with Advanced Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Jun 2007
Akorn, Inc. and Natco Pharma Limited add Two Injectable Drug Products To API Supply and Margin Sharing Agreement
Biopharmaceuticals
 HSMN NewsFeed - 5 Jun 2007
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 May 2007
Auriga Laboratories Appoints Elliot M. Maza To Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2007
Randomized Phase III Trial Showed ERBITUX Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Apr 2007
Data Available from ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Apr 2007
Survival Data Available From ERBITUX(R) Study in First-Line Treatment of Advanced Head and Neck Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Mar 2007
Auriga Laboratories Sales Force Doubles Again to 200 Associates since January
Biopharmaceuticals
 HSMN NewsFeed - 27 Feb 2007
Auriga Settles Lawsuit to Reduce Royalties Payable on Levall Product Line by Approximately $10 Million
Biopharmaceuticals Litigation
 HSMN NewsFeed - 12 Feb 2007
Trevor K. Pokorney Joins Auriga Laboratories Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Feb 2007
ImClone Systems Incorporated and Bristol-Myers Squibb Announce Application In Japan for Use of ERBITUX in Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Jan 2007
MedImmune Announces District Court's Rejection of Sun Pharmaceutical's Motion to End Litigation Regarding Generic Amifostine
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 10 Jan 2007
ERBITUX(R) Phase III Study Meets Primary Endpoint In First-Line Treatment of Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Jan 2007
Auriga Laboratories Appoints Jae Yu As Vice President of Finance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2007
Auriga Laboratories Appoints Richard K. Sampson as National Sales Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2006
Auriga Laboratories Increases Pharmaceutical Sales Representatives
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2006
Auriga Laboratories Appoints Charles R. Bearchell as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Nov 2006
Survival Data Available from Two Randomized ERBITUX Studies in Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Oct 2006
Auriga Laboratories Enters Into Co-Marketing Agreement With Pharmelle LLC for Sale of Company's Aquoral Product
Biopharmaceuticals Urology
 HSMN NewsFeed - 20 Oct 2006
Auriga Expands Brand Portfolio with Exclusive Licensing of Five Prescription Dermatology Products from River's Edge Pharmaceuticals
Biopharmaceuticals Dermatology Licensing
 HSMN NewsFeed - 11 Oct 2006
Cytogen Acquires North American Marketing Rights to CAPHOSOL(R) for Treatment of Both Oral Mucositis and Dry Mouth
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Oct 2006
Auriga Executes Agreement Naming River's Edge Pharmaceuticals as Authorized Generic Distributor of Extendryl and Levall
Biopharmaceuticals Distribution Generics
 HSMN NewsFeed - 18 Sep 2006
Auriga Laboratories Announces Acquisition of Aquoral(TM) Product Line
Biopharmaceuticals Licensing
Return to NewsFeed  

 Additional items found! 10

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 10 additional stories matching:
xerostomia
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.